. 2006 Dec 6;74(2):142–149. doi: 10.1016/j.antiviral.2006.11.004

Table 2.

Suppression efficiency of siRNAs in this stuy (%)

	HBssiRNA2	HBV–HIVsiRNA	HIVsiRNA3	Control
Luciferase activity (pLucF–HBs)	81	82	1	1
Luciferase activity (pLucF–gp120)	1	89	88	1
HBsAg (HepG2.2.15)	81	84	2	1
HBsAg (COS-7)	83	85	0	1
HBV DNA	74	75	1	1
p24 (Fig. 4)	1	82	79	1
p24 (Fig. 7)	0	81	78	1